Answers are grounded in this paper and cite their sources.
Induced pluripotent stem cells (iPSCs) were generated from skin fibroblasts isolated from a healthy woman carrying a mutation in G6PC gene, and from a proband with a clinically and genetically confirmed diagnosis of glycogen storage disease type Ia (G6PC:c.247C>T, p.R83C). The fibroblasts were reprogrammed using non-integrative Sendai viral vectors containing the reprogramming factors OCT4, SOX2, KLF4 and C‑MYC. iPSCs have been shown to express pluripotency markers: OCT4, SSEA4, SOX2 and NANOG. The ability to differentiate into three germ layers was observed in both cell lines (RCMGi015-A: beta III Tubulin, Vimentin, AFP, and RCMGi016-A: beta III Tubulin, Brachyury, FOXA2), cell lines have a normal karyotype (46,XX). Generated iPSC lines can be used for personalized therapy (genome editing) and modelling of glycogen storage disease type Ia.
No takes yet. Share an insight, caveat, or question.
Panchuk et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: